2. Metabolic Enzyme/Protease MAPK/ERK Pathway PI3K/Akt/mTOR Stem Cell/Wnt Apoptosis Protein Tyrosine Kinase/RTK
  3. Endogenous Metabolite MAP3K Akt Mitochondrial Metabolism ERK Apoptosis ROS Kinase
  4. Phosphocreatine disodium

Phosphocreatine disodium  (Synonyms: 磷酸胍酸钠; Disodium creatine phosphate)

目录号: HY-D0885B 纯度: 98.0%
COA 产品使用指南 技术支持

Phosphocreatine (disodium) 是一种存在于脊椎动物骨骼肌中的有机化合物。Phosphocreatine (disodium) 增强抗氧化活性，激活 TAK1 通路以保护心脏。Phosphocreatine (disodium) 通过 Akt 介导的 Nrf2/HO-1 途径使线粒体功能正常化并减少氧化应激。Phosphocreatine (disodium) 通过 ERK 介导的 Nrf-2/HO-1 途径抑制细胞凋亡 (Apoptosis) 和 ROS (Reactive Oxygen Species) 的产生，从而保护肾脏。

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

Phosphocreatine disodium

Phosphocreatine disodium Chemical Structure

CAS No. : 922-32-7

1.  客户无需承担相应的运输费用。

2.  同一机构（单位）同一产品试用装仅限申领一次，同一机构（单位）一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户。

规格 价格 是否有货 数量
10 mM * 1 mL in Water ￥550
In-stock
100 mg ￥500
In-stock
200 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

Phosphocreatine disodium 相关抗体

Top Publications Citing Use of Products

查看 MAP3K 亚型特异性产品:

查看所有亚型
MAP3K7/TAK1 MAP3K8/COT/Tpl2 MAP3K6/ASK2 MAP3K5/ASK1

查看 Akt 亚型特异性产品:

查看所有亚型
Akt Akt1 Akt2 Akt3

查看 ERK 亚型特异性产品:

查看所有亚型
ERK ERK1 ERK2 ERK5 ERK8

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

Phosphocreatine (disodium) is an organic compound found in vertebrate skeletal muscles. Phosphocreatine (disodium) enhances antioxidant activity, and activates the TAK1 pathway to protect the heart. Phosphocreatine (disodium) normalizing mitochondrial function and reducing oxidative stress via Akt mediated Nrf2/HO-1 pathway. Phosphocreatine (disodium) provides renal protection by suppressing Apoptosis and ROS (Reactive Oxygen Species) generation through ERK mediated mediated Nrf-2/HO-1 pathway.[1][2][3][4].

IC50 & Target[1]

Human Endogenous Metabolite

 

体外研究
(In Vitro)

非盐形式：
Phosphocreatine (0-1 mM, 24 h) 通过靶向 TAK1 揭示了抗氧化、抗凋亡和抗坏死性凋亡的作用，以保护 H9c2 细胞免受 DOX (Doxorubicin) (HY-15142A) 诱导的心肌细胞损伤[2]。
Phosphocreatine (0-1 mM, 24 h) 通过增加抗氧化活性来缓解氧化应激，随后将 TAK1 的表达水平恢复到基线水平，并减少 DOX 诱导的心肌损伤中的细胞凋亡和程序性死亡[2]。
Phosphocreatine (5-20 mM, 24 h) 可减轻 MGO (Methylglyoxal) (HY-106634) 诱导的 PC12 细胞损伤和抑制 PC-12 细胞凋亡[3]。
Phosphocreatine (5-20 mM, 24 h) 可防止 MGO (Methylglyoxal) 诱导损伤的 PC-12 细胞线粒体膜通透性丧失[3]。
Phosphocreatine (5-20 mM, 2 h) 对 PC-12 细胞的神经保护作用依赖于通过 Akt 介导的 Nrf2/HO- 1途径使线粒体功能正常化和减少氧化应激[3]。
Phosphocreatine (5-40 mM, 24 h) 在不同浓度下可能有助于保护 NRK-52E 细胞免受 MGO 诱导的肾损伤[4]。
Phosphocreatine (10-40 mM, 4 h) 抑制肾脏氧化应激代谢物[4]。

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Phosphocreatine disodium 相关抗体:

Apoptosis Analysis[3][4]

Cell Line: PC-12, NRK-52E cells
Concentration: 5, 10, 20, 40 mM
Incubation Time: 2 h
Result: Significantly suppressed the enhanced early apoptosis in PC-12 cells in a dose-dependent manner.
Increased the expression of Bcl-2, procaspase-3 and procaspase-9 in NRK-52E cells.
Decreased the expression of Bax and cleaved caspase-3 in NRK-52E cells.
Suppressed karyorrhexis and karyopyknosis in NRK-52E cells.
Decreased the apoptotic rate compared with MGO-treated cells in NRK-52E cells.
Prevented the losing of MMP (mitochondrial membrane potential) in NRK-52E cells.

Cell Viability Assay[3][4]

Cell Line: PC-12, NRK-52E cells
Concentration: 0, 5, 10, 20, 40 mM
Incubation Time: 24 h
Result: Was not toxic to PC-12 cells under the treatment conditions.
Significantly increased PC-12 cell viability at the concentrations of 5, 10 and 20 mM compared with MGO (Methylglyoxal) (HY-106634) groups.
Contributed to protection of the NRK-52E cells against MGO-induced kidney injury.

Western Blot Analysis[3][4]

Cell Line: PC-12, NRK-52E cells
Concentration: 20, 40 mM
Incubation Time: 24 h
Result: Increased the expression levels of Akt, Nrf2 (nuclear factor (erythroid-derived-2)-like 2 (Nrf2)) and HO-1 (Hemeoxygenase-1) in PC12 cells.
Increased the expression of nuclear Nrf2 levels, and decreased Nrf2 level in PC12 cells cytoplasm.
Increased the expression of p-Akt, HO-1 and Nrf2 with compared with pre-treatment for 2 h with LY294002 (a PI3K inhibitor) in PC12 cells.
Significantly increased Bcl-2 and procaspase-9 levels and decreased Bax, cleaved caspase-9 and cleaved caspase-3 C level in NRK-52E cells.
Decreased the expression of p-ERK and increased the Nrf2 and HO-1 expressions in NRK-52E cells.
体内研究
(In Vivo)

非盐形式：
Phosphocreatine (200 mg/kg, i.p., 每隔一天一次, 7 周) 不仅减轻了氧化应激和心肌细胞凋亡，而且挽救了 DOX 诱导的大鼠心脏毒性中的心肌坏死[2]。
Phosphocreatine (20-40 mg/kg, i.v., 每天, 6 周) 对 SD (Sprague-Dawley) 大鼠的肾组织具有保护作用，可预防糖尿病肾病[4]。

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Male Sprague Dawley (SD) rats, i.p., normal saline, 3 times; i.p., DOX 2 mg/kg, 7 times; i.p., normal saline, 3 times [2]
Dosage: 200 mg/kg
Administration: i.p., once every other day, 7 weeks
Result: Improved the heart function abnormality.
Lowered myocardial apoptosis.
Recovered the expression of Nrf2, SOD, FoxO3a and diminished C-Casp3, Bax/Bcl2 in the myocardial tissue of rats.
Markedly improved myocardial necroptosis, as indicated by decreasing expression of RIP3 and CaMKII.
Increased expression level of TAK1.
Animal Model: Male Sprague Dawley (SD) rats, i.p., 70 mg/kg (STZ(Streptozotocin) (HY-13753)), daily, 6 weeks [4]
Dosage: 20, 40 mg/kg
Administration: i.p., daily, 6 weeks
Result: Reduced hyperglycemia compared with STZ (Streptozotocin) (HY-13753) -treated rats.
Increased the weight of rats gradually compared with STZ (Streptozotocin) (HY-13753) group.
Decreased kidney weight index (kidney weight/body weight).
Decreased MDA level and increased of GSH and SOD levels compared with STZ group.
Decreased the apoptotic rate compared with MGO-treated groups.
Clinical Trial
分子量

255.08

Formula

C4H8N3Na2O5P
CAS 号
性状

固体

颜色

White to off-white

中文名称

磷酸胍酸钠
结构分类
初始来源
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

4°C, sealed storage, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

溶解性数据
细胞实验： 

H2O 中的溶解度 : 125 mg/mL (490.04 mM; 超声助溶)

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 3.9203 mL 19.6017 mL 39.2034 mL
5 mM 0.7841 mL 3.9203 mL 7.8407 mL
查看完整储备液配制表

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。
储备液的保存方式和期限：-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)。-80°C储存时，请在6个月内使用，-20°C储存时，请在1个月内使用。

* 备注：如您选择水作为储备液，请稀释至工作液后，再用 0.22 μm 的滤膜过滤除菌后使用。

  • 摩尔计算器

  • 稀释计算器

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量
=
浓度
×
体积
×
分子量 *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start)

C1

×
体积 (start)

V1

=
浓度 (final)

C2

×
体积 (final)

V2

动物实验：

以下溶解方案，请直接配制工作液。建议现用现配，在短期内尽快用完。 以下溶剂前显示的百分比是指该溶剂在您配制终溶液中的体积占比； 如在配制过程中出现沉淀、析出现象，可以通过加热和/或超声的方式助溶。

  • 方案 一

    请依序添加每种溶剂： PBS

    Solubility: 100 mg/mL (392.03 mM); 澄清溶液; 超声助溶

动物溶解方案计算器
请输入动物实验的基本信息：

给药剂量

mg/kg

动物的平均体重

g

每只动物的给药体积

μL

动物数量

只
由于实验过程有损耗，建议您多配一只动物的量
计算结果
工作液所需浓度 : mg/mL
该产品水溶性佳，请具体参考实测 水 / PBS / Saline 中的溶解度数据。
您所需的储备液浓度超过该产品的实测溶解度，如有需要，请与 MCE 中国技术支持联系。
纯度 & 产品资料
参考文献

Phosphocreatine disodium 相关分类

完整储备液配制表

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。
储备液的保存方式和期限：-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)。-80°C储存时，请在6个月内使用，-20°C储存时，请在1个月内使用。

可选溶剂 浓度 溶剂体积 质量 1 mg 5 mg 10 mg 25 mg
H2O 1 mM 3.9203 mL 19.6017 mL 39.2034 mL 98.0085 mL
5 mM 0.7841 mL 3.9203 mL 7.8407 mL 19.6017 mL
10 mM 0.3920 mL 1.9602 mL 3.9203 mL 9.8008 mL
15 mM 0.2614 mL 1.3068 mL 2.6136 mL 6.5339 mL
20 mM 0.1960 mL 0.9801 mL 1.9602 mL 4.9004 mL
25 mM 0.1568 mL 0.7841 mL 1.5681 mL 3.9203 mL
30 mM 0.1307 mL 0.6534 mL 1.3068 mL 3.2669 mL
40 mM 0.0980 mL 0.4900 mL 0.9801 mL 2.4502 mL
50 mM 0.0784 mL 0.3920 mL 0.7841 mL 1.9602 mL
60 mM 0.0653 mL 0.3267 mL 0.6534 mL 1.6335 mL
80 mM 0.0490 mL 0.2450 mL 0.4900 mL 1.2251 mL
100 mM 0.0392 mL 0.1960 mL 0.3920 mL 0.9801 mL

* 备注：如您选择水作为储备液，请稀释至工作液后，再用 0.22 μm 的滤膜过滤除菌后使用。

Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Phosphocreatine disodium922-32-7Disodium creatine磷酸胍酸钠Endogenous MetaboliteMAP3KAktMitochondrial MetabolismERKApoptosisROS KinaseMAP kinase kinase kinase, MEKK, MAPKKKPKBProtein kinase BExtracellular signal regulated kinasesATPmuscle contractioncardiotoxicitymitochondrial functionoxidative stressInhibitorinhibitorinhibit

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称：

  

* 需求量：

* 客户姓名：

 

* Email：

* 电话：

 

* 公司或机构名称：

   留言给我们：

Bulk Inquiry

Inquiry Information

产品名称：
Phosphocreatine disodium
目录号：
HY-D0885B
需求量：

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

   产品名称：

  

* Lot #：

* 客户姓名：

 

* Email：

   电话：

 

* 部门：

* 公司或机构名称：

 

   留言给我们：

Request for HNMR Report

We have received your request and will respond to you as soon as possible.

嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z